Publications by authors named "E Bachy"

Claim this Profile
P
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
N Alshatti, F Lemonnier, E Bachy, J Lopez, F Llamas

Immunooncol Technol· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, Christopher R Flowers, Diego Villa, Emmanuel Bachy

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphoma.
Emilie Charton, Amélie Anota, Emmannuel Bachy, Guillaume Cartron, Francois-Xavier Gros

Blood Adv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis.
Jean Galtier, Pierre Sesques, Vivien Dupont, Emmanuel Bachy, Roberta Di Blasi

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium.
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, Edith Julia, Emmannuel Bachy

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis